Victoria Hillerdal

Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice

Victoria Hillerdal, Mohanraj Ramachandran, Justyna Leja et al. · BMC Cancer · 2014 · 59 citations · Full text

Medicine, Immunology, Oncology +17

Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors

Chuan Jin, Di Yu, Victoria Hillerdal et al. · Molecular Therapy — Methods & Clinical Development · 2014 · 51 citations · Full text

Life Sciences, Cell Biology, Immunology +17

T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2 ⁺ prostate and breast cancer cells

Victoria Hillerdal, Berith Nilsson, Björn Carlsson et al. · Proceedings of the National Academy of Sciences · 2012 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17

Avidity characterization of genetically engineered T-cells with novel and established approaches

Victoria Hillerdal, Vanessa F. Boura, Hanna Björkelund et al. · BMC Immunology · 2016 · 18 citations · Full text

Life Sciences, Immunology, Molecular Biology +17